Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on US National Times.
Global Yeast Market Rising Fast: Set to Reach USD 8.5 Billion by 2029 | Asia-Pacific Leads the Market’s Next Growth Wave
Delray Beach, FL, Nov. 03, 2025 (GLOBE NEWSWIRE) -- According to a research report published by MarketsandMarkets, The global yeast market is rising fast, projected to grow from USD 5.5 billion in 2024 to USD 8.5 billion by 2029, registering a...
Milestone Pharmaceuticals to Present New Analysis from Investigational Etripamil Nasal Spray Clinical Trials for PSVT at the American Heart Association Scientific Sessions 2025
MONTREAL and CHARLOTTE, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced...
St. Mark’s United Methodist Church to Host Lincoln’s Largest Veterans Day Celebration
Community invited to honor veterans, active-duty service members, and their families LINCOLN, NE, UNITED STATES, November 3, 2025 /EINPresswire.com/ -- St. Mark’s United Methodist Church will host the largest Veterans Day celebration in...
Electra Reactivates Construction at Cobalt Sulfate Refinery
TORONTO, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”), a leader in advancing North America’s critical minerals processing, has resumed construction at its cobalt...
Sportradar Reports Third Quarter Financial Results, Raises Full Year 2025 Outlook and Announces Increase in Share Repurchase Program to $300 Million
Third Quarter 2025 Highlights Revenue increased 14% to €292 million Generated profit for the period of €22 million, 7.7% as a percentage of revenue Adjusted EBITDA1 increased 29% to €85 million and Adjusted EBITDA margin1 expanded to a record...
Biomea Fusion Showcases Preclinical Advances for BMF-650 and Icovamenib with Low Dose Semaglutide at ObesityWeek® 2025
The Company’s investigational small molecule glucagon-like peptide-1 (“GLP-1”) receptor agonist (“RA”), BMF-650, demonstrated potent weight loss and good tolerability in obese cynomolgus monkeys A Phase I study of BMF-650 in healthy obese patients...
H World Group Limited Schedules Third Quarter of 2025 Earnings Release on November 17, 2025
SINGAPORE and SHANGHAI, Nov. 05, 2025 (GLOBE NEWSWIRE) -- H World Group Limited (NASDAQ: HTHT and HKEX: 1179) (“H World”, “we” or “our”) a key player in the global hotel industry, today announced that it will schedule to release its unaudited...
trivago Maintains Strong Momentum in Q3, Delivering 13% Growth
Exhibit 99.1 Operating and Financial Review DÜSSELDORF, GERMANY - November 4, 2025 – trivago N.V. (NASDAQ: TRVG) (the “Company”, “we,” “us,” “our,” or “trivago,”) announced financial results for the third quarter ended September 30, 2025....
Taboola Reports Strong Q3 2025 Financial Results, Surpassing High-End of Guidance; Raises Full-Year Outlook
NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Taboola (Nasdaq: TBLA), a global leader in delivering performance at scale for advertisers, today announced its results for the third quarter ended September 30, 2025. "We delivered another strong...
Colombia Mulls Pursuing UN Proposal to Halt U.S. Caribbean Strikes
(MENAFN) Colombian President Gustavo Petro declared Friday that his nation should pursue a United Nations proposal to halt US airstrikes targeting suspected drug trafficking vessels in Caribbean waters. In a post on US social media platform X,...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
X4 Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Company’s strategic focus and highest priority is now the advancement of the 4WARD Phase 3 chronic neutropenia trial Previously announced workforce reductions resulted in $13M annualized cost savings Successful completion of two financial...
Oculis to Participate in Upcoming November Investor Conferences
ZUG, Switzerland, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology...
Upstream Bio Reports Third Quarter 2025 Financial Results and Highlights Continued Progress
– Positive top-line results from VIBRANT Phase 2 trial of verekitug in CRSwNP reported in September showed statistically significant and clinically meaningful effects on primary and key secondary endpoints when administered once every 12 weeks – –...
Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the second neuro map designed to accelerate treatments for a wide range of neurological diseases With this achievement, Recursion...
Atea Pharmaceuticals to Host Third Quarter 2025 Financial Results and Business Update Conference Call on November 12, 2025
BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases,...
Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025
BURLINGTON, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes of obesity and type 2 diabetes (T2D), today...